Literature DB >> 8558914

The adhesion molecule E-cadherin and a surface antigen recognized by the antibody 9C4 are selectively expressed on erythroid cells of defined maturational stages.

H J Bühring1, T Müller, R Herbst, S Cole, I Rappold, W Schuller, X Zhu, U Fritzsch, C Faul, S Armeanu, A Ullrich, G Klein, H Schmidt.   

Abstract

The antigen expression of immature erythroid bone marrow cells was studied using two recently generated monoclonal antibodies (mAb), mAb 67A4 and 9C4, with specificities for the epithelial cell adhesion molecule E-cadherin (E-cad; mAb 67A4), and a novel 110 kDa differentiation antigen (mAb 9C4) with unknown molecular structure. Pappenheim staining of FACS-purified cells labeled with mAb 9C4 and anti-glycophorin A (GA) revealed that the majority of the 9C4+GA- and 9C4+GA+ cells consisted of erythroblasts. In contrast, the E-cad-positive population comprised normoblasts and erythroblasts. While the E-cad+GA- fraction contained mainly erythroblasts and basophilic normoblasts, the E-Cad+GA+ population was enriched in orthochromatic and polychromatophilic normoblasts. By colony assays of affinity column-purified cells it could be shown that erythroid colony forming units (CFU-E) were enriched and erythroid burst forming units (BFU-E) were depleted in the 9C4- and E-cad-positive fractions. Flow cytometric analysis of bone marrow cells double-labeled with mAb 67A4 and anti-CD71, anti-CD117, anti-CD34, or anti-GA revealed that about 90% of the E-cad-positive cells coexpressed CD71, about 70% were positive for CD117, about 50% for GA, and only about 5% coexpressed CD34. The expression pattern of 9C4 antigen was similar to that of E-Cad with the exception that only a minority of the 9C4-positive cells coexpressed GA. Lymphoid and myeloid markers were negative on both the E-Cad- and 9C4-positive populations. In these studies we describe the identification of a new mAb-defined antigen which is specifically expressed on erythroblasts and CFU-E(9C4) and demonstrate that E-Cad is not only expressed on epithelial cells but also on erythropoietic cells of defined maturational stages.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8558914

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  6 in total

1.  EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes.

Authors:  J J M van Dongen; L Lhermitte; S Böttcher; J Almeida; V H J van der Velden; J Flores-Montero; A Rawstron; V Asnafi; Q Lécrevisse; P Lucio; E Mejstrikova; T Szczepański; T Kalina; R de Tute; M Brüggemann; L Sedek; M Cullen; A W Langerak; A Mendonça; E Macintyre; M Martin-Ayuso; O Hrusak; M B Vidriales; A Orfao
Journal:  Leukemia       Date:  2012-05-03       Impact factor: 11.528

2.  Erythroid differentiation of myeloblast induced by gilteritinib in relapsed FLT3-ITD-positive acute myeloid leukemia.

Authors:  Hyun Don Yun; Sunita Nathan; Melissa Larson; Mohammad J Hussain; Deborah A Katz; Ankur Varma; Ira Miller; Celalettin Ustun
Journal:  Blood Adv       Date:  2019-11-26

3.  Complex karyotype with novel translocation in pure erythroid leukemia patient.

Authors:  Mansour Aljabry
Journal:  Hematol Rep       Date:  2015-03-16

4.  Report on antibodies submitted to the stromal cell section of HLDA8.

Authors:  Christopher D Buckley; Sapna Halder; Debbie Hardie; Garry Reynolds; Ruurd Torensma; Vanina Jodon De Villeroche; Daniele Brouty-Boye; Clare M Isacke
Journal:  Cell Immunol       Date:  2005-09-19       Impact factor: 4.868

Review 5.  An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin.

Authors:  Andrew M Bellizzi
Journal:  Adv Anat Pathol       Date:  2020-05       Impact factor: 4.571

Review 6.  Normal and pathological erythropoiesis in adults: from gene regulation to targeted treatment concepts.

Authors:  Peter Valent; Guntram Büsche; Igor Theurl; Iris Z Uras; Ulrich Germing; Reinhard Stauder; Karl Sotlar; Wolfgang Füreder; Peter Bettelheim; Michael Pfeilstöcker; Rainer Oberbauer; Wolfgang R Sperr; Klaus Geissler; Jürg Schwaller; Richard Moriggl; Marie C Béné; Ulrich Jäger; Hans-Peter Horny; Olivier Hermine
Journal:  Haematologica       Date:  2018-08-03       Impact factor: 9.941

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.